Contents:
What it mainly lacks is another pages. The emotional baggage that makes you love or hate the characters. Another issue I had is with the writing style. Well maybe not writing style per I read it in one sitting. Well maybe not writing style per say, since some sentences were pure poetry. But here is the problem with elaborate sentences and words. They break the flow of the reading.
So far I never had so many issues and here I was…thanking kindle cloud reader for having a dictionary. While this is very good for my self-learning, I dislike it while reading because it breaks the flow.
Carol Palmer rated it it was amazing Oct 02, Thomas rated it liked it Dec 09, Jennifer Oliver rated it it was amazing Nov 06, Ellen added it Feb 07, Adam Chance marked it as to-read Aug 05, RoseMarie Cadavos is currently reading it Oct 09, The retrospective nature of our study prevents us from establishing a causal relationship between encounter frequency and patient outcomes. A randomized interventional study is therefore needed to definitively establish optimal encounter frequency for patients with diabetes.
The authors have no significant primary financial arrangements with commercial companies that produce or sell products that are the subject of studies reported in the manuscript, or with competitors of such companies. No potential conflicts of interest relevant to the article were reported. National Center for Biotechnology Information , U. Author manuscript; available in PMC Jun Author information Copyright and License information Disclaimer. The publisher's final edited version of this article is available at Arch Intern Med.
See other articles in PMC that cite the published article. Abstract Background More frequent patient-provider encounters may lead to faster A1c, blood pressure and LDL control and improve outcomes but there are no guidelines for how frequently patients with diabetes should be seen. Results Comparing patients who had encounters with their physicians between weeks vs.
Conclusions Biweekly primary care provider encounters are associated with fastest achievement of A1c, blood pressure, and LDL targets for patients with diabetes. Study Measurements A single uncontrolled period served as the unit of analysis. Statistical Analysis Summary statistics were conducted by using frequencies and proportions for categorical data and using means, standard deviations, medians, and ranges for continuous variables. Open in a separate window. Table 2 Uncontrolled Period Characteristics.
Encounter Interval and Time to Treatment Target Achievement In all treatment categories, time to treatment target rose progressively as the interval between encounters increased Figure 2. Encounter Frequency and Time to Combined Target. Encounter Interval and Rates of Outcome Measure Change In multivariable analysis adjusted for demographic characteristics, CCI, insulin treatment in hyperglycemic patients , highest A1c, BP and LDL where relevant during the uncontrolled period, rate of treatment intensification and A1c and LDL measurement where relevant , and clustering within individual physicians and repeated measurements within patients, for every additional month between encounters, rate of A1c decrease declined an additional 0.
Footnotes The authors have no significant primary financial arrangements with commercial companies that produce or sell products that are the subject of studies reported in the manuscript, or with competitors of such companies. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.
Global prevalence of diabetes: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease.
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: Achievement of American Diabetes Association clinical practice recommendations among U. Prevalence, treatment, and control of diagnosed diabetes in the U. National Health and Nutrition Examination Survey Relationship between patient panel characteristics and primary care physician clinical performance rankings.
Encounter frequency and blood pressure in hypertensive patients with diabetes mellitus. Visit frequency and hypertension.
J Clin Hypertens Greenwich Jun; 7 6: ADA Standards of medical care in diabetes Medical management of hyperglycemia in type 2 diabetes: Standards of medical care for patients with diabetes mellitus. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. Effect of board certification on antihypertensive treatment intensification in patients with diabetes mellitus.
Inadequate management of blood pressure in a hypertensive population. Using regular expressions to abstract blood pressure and treatment intensification information from the text of physician notes. J Am Med Inform Assoc. Comparison of information content of structured and narrative text data sources on the example of medication intensification.
Cox regression analysis of multivariate failure time data: Principles of multilevel modelling. An improved Bonferroni procedure for multiple tests of significance. A sharper Bonferroni procedure for multiple tests of significance. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM.
Results of two multicenter, randomized, placebo-controlled clinical trials.
Repaglinide versus nateglinide monotherapy: Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes LEAD-1 SU. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.
Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: Int J Clin Pract. Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: Concentration-effect relationships and individual responses to doxazosin in essential hypertension.
Br J Clin Pharmacol. Kinetic-dynamic relations and individual responses to enalapril. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension. Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders.
Pressure: First Encounter - Kindle edition by Alex Beyman, Eddy Gerina. Download it once and read it on your Kindle device, PC, phones or tablets. Use features. Pressure has 4 ratings and 1 review. Kalina said: I read it in one sitting. Yes partly because doh it is a short story. But you know that even short stor.
The idea that "everyone's doing it" can influence some kids to leave their better judgment, or their common sense, behind. It is tough to be the only one who says "no" to peer pressure, but you can do it. Paying attention to your own feelings and beliefs about what is right and wrong can help you know the right thing to do.
Inner strength and self-confidence can help you stand firm, walk away, and resist doing something when you know better. It can really help to have at least one other peer, or friend, who is willing to say "no," too. This takes a lot of the power out of peer pressure and makes it much easier to resist. It's great to have friends with values similar to yours who will back you up when you don't want to do something.
You've probably had a parent or teacher advise you to "choose your friends wisely. If you choose friends who don't use drugs , cut class, smoke cigarettes, or lie to their parents, then you probably won't do these things either, even if other kids do. Try to help a friend who's having trouble resisting peer pressure. It can be powerful for one kid to join another by simply saying, "I'm with you — let's go. Even if you're faced with peer pressure while you're alone, there are still things you can do.
You can simply stay away from peers who pressure you to do stuff you know is wrong. You can tell them "no" and walk away. Better yet, find other friends and classmates to pal around with. If you continue to face peer pressure and you're finding it difficult to handle, talk to someone you trust.